Results 1 to 8 of 8

Drug monitoring for toxicity

  1. #1
    Location
    Kansas City, MO
    Posts
    431
    Question Drug monitoring for toxicity
    Exam Training Packages
    I very recently heard in a teleconference or a webinar that there is a list available of "drugs that require intensive monitoring for toxicity" and that coumadin was NOT on it. Unfortunaltely I can find my note, or remember the source. Does anyone know if such a list truly exists?
    Linda Vargas, CPC, CPCO, CPMA, CPC-I, CEMC,CCC
    PMCC Licensed Instructor
    Kansas City, MO Chapter
    President, 2018
    Vice President, 2017
    Member Development Officer 2016
    Harrisonville, MO Chapter President - 2013
    ICD-10 Education Coordinator- 2012
    Chapter President - 2011
    President Elect - 2010

  2. #2
    Location
    Greeley, Colorado
    Posts
    2,045
    Default
    V58.61 is specically for anticoagulants (coumadin).
    Lisa Bledsoe, CPC, CPMA

  3. #3
    Location
    Columbia, MO
    Posts
    12,572
    Default
    Quote Originally Posted by LINDALOUV View Post
    I very recently heard in a teleconference or a webinar that there is a list available of "drugs that require intensive monitoring for toxicity" and that coumadin was NOT on it. Unfortunaltely I can find my note, or remember the source. Does anyone know if such a list truly exists?
    I cannot imagine that such a list does exist, the doctor I questioned stated that any and all drugs need to be monitored for toxicity, it is just the manner in which they are monitored. Sometimes you just observe or examine the patient other times you draw labs, or get urine samples, or even a diagnostic study.
    According to coding clinics drug monitoring regardless of how it is being performed should be coded to V58.83 followed by the V58.6x code. V58.6x is secondary only allowed.

    Debra A. Mitchell, MSPH, CPC-H

  4. #4
    Location
    Kansas City, MO
    Posts
    431
    Default
    Thanks for responding ladies.

    The actual reason I ask is for use when it comes to determining risk during an audit. In the "HIGH" risk column it lists "drug therapy requiring intensive monitoring for toxicity"

    I have a rheumatologist who list this in his assesment almost everytime.
    I have Fam Prac docs who use this statement as well, especially for Coumadin.

    When auditing this is often the deciding factor for a level 5. I was jus wondering as far as the table of risk goes, how I would determine to give credit for this during a chart audit.
    Linda Vargas, CPC, CPCO, CPMA, CPC-I, CEMC,CCC
    PMCC Licensed Instructor
    Kansas City, MO Chapter
    President, 2018
    Vice President, 2017
    Member Development Officer 2016
    Harrisonville, MO Chapter President - 2013
    ICD-10 Education Coordinator- 2012
    Chapter President - 2011
    President Elect - 2010

  5. #5
    Location
    Milwaukee WI
    Posts
    4,466
    Default INTENSIVE monitoring
    To me the key here is "INTENSIVE" monitoring for toxicity.

    I interpret that as being virtually continuous monitoring of the type done in a hospital or office setting. Not the kind of monitoring that is done by having the patient return on a regular basis for blood work or other checks of drug levels/advserse effects.

    Just my opinion/interpretation.

    F Tessa Bartels, CPC, CEMC

  6. #6
    Post
    http://www.palmettogba.com/Palmetto/...r_Toxicity.pdf

    I found this list when researching this subject as well as this forum.
    I hope this helps.

  7. #7
    Default
    Very interesting list/post. Thanks for posting.

  8. Default Drug monitoring for toxicity Reply
    Here is a link for Palmetto regarding a table of risk lists drug therapy requiring intensive monitoring: http://www.palmettogba.com/Palmetto/...?open&Expand=1

Similar Threads

  1. Drug Administration and Monitoring
    By lao1960 in forum Medical Coding General Discussion
    Replies: 0
    Last Post: 02-10-2015, 03:02 PM
  2. Therapeutic drug monitoring
    By Atlantic2013 in forum Diagnosis Coding
    Replies: 0
    Last Post: 12-02-2014, 12:10 PM
  3. Coumadin Toxicity & Digoxin Toxicity
    By JGALAPIA in forum Diagnosis Coding
    Replies: 13
    Last Post: 12-15-2010, 08:44 PM
  4. Drug Monitoring
    By bkilgroe in forum Medical Coding General Discussion
    Replies: 0
    Last Post: 09-27-2010, 11:56 AM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •  
Enjoying Our Forums?

AAPC forums are a benefit of membership. Joining AAPC grants you unlimited access, allowing you to post questions and participate with our community of over 150,000 professionals.

Join Now Continue Reading Without Full Access

Already a Member?

Login

Close Message

In addition to full participation on AAPC forums, as a member you will be able to:

  • Access to the largest healthcare job database in the world.
  • Join over 150,000 members of the healthcare network in the world.
  • Be a part of an industry leading organization that drives the business side of healthcare.
  • Save anywhere from 10%-50% with exclusive member discounts on courses, books, study materials, and conferences.
  • Access to discounts at hundreds of restaurants, travel destinations, retail stores, and service providers. AAPC members also have opportunities to save on heath, life, and liability insurance.
  • Become a member of a local chapter and attend regular meetings.